{"id":"https://openalex.org/W2740097138","doi":"https://doi.org/10.1158/1538-7445.am2017-3748","title":"Abstract 3748: Development of anti-human mesothelin chimeric antigen receptor (CAR) messenger RNA (mRNA) transfected peripheral blood mononuclear cells (CARMA) for the treatment of mesothelin-expressing cancers","display_name":"Abstract 3748: Development of anti-human mesothelin chimeric antigen receptor (CAR) messenger RNA (mRNA) transfected peripheral blood mononuclear cells (CARMA) for the treatment of mesothelin-expressing cancers","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2740097138","doi":"https://doi.org/10.1158/1538-7445.am2017-3748","mag":"2740097138"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-3748","doi":"https://doi.org/10.1158/1538-7445.am2017-3748","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-3748","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003534152","display_name":"Chien\u2010Fu Hung","orcid":"https://orcid.org/0000-0001-9170-7797","observed_orcids":["https://orcid.org/0000-0001-9170-7797"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chien-Fu Hung","raw_affiliation_strings":["1Johns Hopkins University, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Johns Hopkins University, Baltimore, MD;","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033553786","display_name":"Xuequn Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xuequn Xu","raw_affiliation_strings":["1Johns Hopkins University, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Johns Hopkins University, Baltimore, MD;","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103089842","display_name":"Linhong Li","orcid":"https://orcid.org/0000-0002-1732-3020","observed_orcids":["https://orcid.org/0000-0002-1732-3020"]},"institutions":[{"id":"https://openalex.org/I4210122402","display_name":"MaxCyte (United States)","ror":"https://ror.org/0317phh79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122402"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linhong Li","raw_affiliation_strings":["2MaxCyte, Inc., Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MaxCyte, Inc., Gaithersburg, MD;","institution_ids":["https://openalex.org/I4210122402"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084708534","display_name":"Ying Ma","orcid":"https://orcid.org/0000-0003-3282-4410","observed_orcids":["https://orcid.org/0000-0003-3282-4410","https://orcid.org/0009-0004-0001-1276"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ying Ma","raw_affiliation_strings":["1Johns Hopkins University, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Johns Hopkins University, Baltimore, MD;","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100842403","display_name":"Jin Qiu","orcid":"https://orcid.org/0009-0007-5464-1806","observed_orcids":["https://orcid.org/0009-0007-5464-1806"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qiu Jin","raw_affiliation_strings":["1Johns Hopkins University, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Johns Hopkins University, Baltimore, MD;","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073654207","display_name":"Angelia M. Viley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122402","display_name":"MaxCyte (United States)","ror":"https://ror.org/0317phh79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122402"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angelia Viley","raw_affiliation_strings":["2MaxCyte, Inc., Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MaxCyte, Inc., Gaithersburg, MD;","institution_ids":["https://openalex.org/I4210122402"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108215021","display_name":"Cornell Allen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122402","display_name":"MaxCyte (United States)","ror":"https://ror.org/0317phh79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122402"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cornell Allen","raw_affiliation_strings":["2MaxCyte, Inc., Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MaxCyte, Inc., Gaithersburg, MD;","institution_ids":["https://openalex.org/I4210122402"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112306493","display_name":"Pachai Natarajan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122402","display_name":"MaxCyte (United States)","ror":"https://ror.org/0317phh79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122402"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pachai Natarajan","raw_affiliation_strings":["2MaxCyte, Inc., Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MaxCyte, Inc., Gaithersburg, MD;","institution_ids":["https://openalex.org/I4210122402"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027188179","display_name":"Rama Shivakumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122402","display_name":"MaxCyte (United States)","ror":"https://ror.org/0317phh79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122402"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rama Shivakumar","raw_affiliation_strings":["2MaxCyte, Inc., Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MaxCyte, Inc., Gaithersburg, MD;","institution_ids":["https://openalex.org/I4210122402"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111784770","display_name":"Madhusudan V. Peshwa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122402","display_name":"MaxCyte (United States)","ror":"https://ror.org/0317phh79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122402"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Madhusudan V. Peshwa","raw_affiliation_strings":["2MaxCyte, Inc., Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MaxCyte, Inc., Gaithersburg, MD;","institution_ids":["https://openalex.org/I4210122402"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012487596","display_name":"Leisha A. Emens","orcid":"https://orcid.org/0000-0002-7694-0731","observed_orcids":["https://orcid.org/0000-0002-7694-0731"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leisha A. Emens","raw_affiliation_strings":["3Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"3748","last_page":"3748"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mesothelin","display_name":"mesothelin","score":0.9459999799728394},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor","display_name":"chimeric antigen receptor","score":0.9580000042915344},{"id":"https://openalex.org/keywords/mrna-transfection","display_name":"mRNA transfection","score":0.8169999718666077},{"id":"https://openalex.org/keywords/carma","display_name":"CARMA","score":0.5870000123977661},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.9210000038146973},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.7390000224113464},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7580000162124634},{"id":"https://openalex.org/keywords/on-target-off-tumor-toxicity","display_name":"on-target off-tumor toxicity","score":0.9300000071525574},{"id":"https://openalex.org/keywords/intraperitoneal-injection","display_name":"intraperitoneal injection","score":0.6919999718666077},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.41499999165534973},{"id":"https://openalex.org/keywords/peritoneal-metastases","display_name":"peritoneal carcinomatosis","score":0.6420000195503235},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.593999981880188},{"id":"https://openalex.org/keywords/tumor-cell-lysis","display_name":"tumor cell lysis","score":0.38600000739097595},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.43799999356269836},{"id":"https://openalex.org/keywords/mouse-tumor-model","display_name":"mouse tumor model","score":0.5350000262260437}],"concepts":[{"id":"https://openalex.org/C2777045440","wikidata":"https://www.wikidata.org/wiki/Q14914057","display_name":"Mesothelin","level":3,"score":0.8579950332641602},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.652455747127533},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.579258143901825},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5605181455612183},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.5588163137435913},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5139855742454529},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49633079767227173},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.45730096101760864},{"id":"https://openalex.org/C2776662205","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor antigen","level":4,"score":0.41695404052734375},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3674602508544922},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3601881265640259},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3037741780281067},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2533438205718994},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-3748","doi":"https://doi.org/10.1158/1538-7445.am2017-3748","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-3748","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2783022904","https://openalex.org/W2133298966","https://openalex.org/W2318688713","https://openalex.org/W4295226699","https://openalex.org/W2978477867","https://openalex.org/W2336405815","https://openalex.org/W7162512323","https://openalex.org/W3129250092","https://openalex.org/W1981955743","https://openalex.org/W4403250138"],"abstract_inverted_index":{"Abstract":[0],"CD19-targeted":[1],"chimeric":[2,299],"antigen":[3,300],"receptor":[4,301],"(CAR)-engineered":[5],"T/NK-cell":[6],"therapies":[7],"can":[8],"result":[9],"in":[10,14,24,136,146,158,169,187],"durable":[11],"clinical":[12,125],"responses":[13],"B-cell":[15],"malignancies.":[16],"However,":[17],"CAR-based":[18],"immunotherapies":[19],"have":[20],"been":[21],"less":[22],"successful":[23],"solid":[25,267],"cancers.":[26],"This":[27],"is":[28,96],"partly":[29],"due":[30],"to":[31,45,65,168],"specificity":[32],"for":[33,112,124,155,248,266,312,325],"shared":[34],"tumor":[35,144,192],"antigens":[36],"also":[37],"present":[38],"on":[39],"normal":[40],"host":[41],"tissues":[42],"that":[43],"leads":[44],"\u2018on-target/off-tumor\u2019":[46,70],"toxicity.":[47,71],"We":[48,100],"therefore":[49,101],"developed":[50],"a":[51,107,161,174,179,245],"non-viral":[52],"approach":[53],"using":[54,106],"repeated":[55],"infusions":[56],"of":[57,69,77,83,94,105,138,151,164,184,191,200,206,219,226,239,262,264,296,315,321],"mesothelin-specific":[58],"messenger":[59,303],"RNA":[60,304],"(mRNA)":[61,305],"CAR-transfected":[62],"T":[63],"cells":[64,123,145,310],"permit":[66],"prospective":[67],"control":[68,213],"Early":[72],"trials":[73],"provided":[74],"preliminary":[75],"evidence":[76],"the":[78,87,103,188,196,207,256,313,322],"safety":[79],"and":[80,92,98,140,142,194,214,251,258],"anti-tumor":[81],"activity":[82],"this":[84],"strategy,":[85],"but":[86],"ex":[88],"vivo":[89],"selection,":[90],"activation":[91],"expansion":[93],"lymphocytes":[95],"laborious":[97],"expensive.":[99],"explored":[102],"feasibility":[104],"rapid,":[108],"automated,":[109],"closed":[110],"system":[111],"cGMP-compliant":[113],"mRNA":[114],"CAR":[115,135,152,165],"transfection":[116],"into":[117],"freshly":[118],"isolated":[119],"peripheral":[120,307],"blood":[121,308],"mononuclear":[122,309],"scale":[126],"manufacture":[127],"(CARMA).":[128],"The":[129],"resulting":[130],"cryopreserved":[131],"cellular":[132],"product":[133],"expressed":[134],">95%":[137],"cells,":[139],"recognized":[141],"lysed":[143],"an":[147,223],"antigen-specific":[148],"manner.":[149],"Expression":[150],"was":[153],"detectable":[154],"5-7":[156],"days":[157],"vitro,":[159],"with":[160,222],"progressive":[162],"decline":[163],"expression":[166],"related":[167],"vitro":[170],"cell":[171],"expansion.":[172],"In":[173],"murine":[175],"ovarian":[176,249],"cancer":[177,250],"model,":[178],"single":[180],"intra-peritoneal":[181],"(IP)":[182],"injection":[183],"CARMA":[185,209,242,265],"resulted":[186],"dose-dependent":[189],"inhibition":[190],"growth":[193],"prolonged":[195,216],"overall":[197],"survival":[198],"(OS)":[199],"mice.":[201],"Multiple":[202],"weekly":[203],"IP":[204,241],"injections":[205],"optimal":[208],"dose":[210],"enhanced":[211],"disease":[212],"further":[215,237],"OS,":[217],"both":[218],"which":[220],"improved":[221],"increasing":[224],"number":[225],"injections.":[227],"No":[228],"significant":[229],"off-tumor":[230],"toxicities":[231],"were":[232],"observed.":[233],"These":[234],"data":[235],"support":[236],"investigation":[238],"serial":[240],"administration":[243],"as":[244],"potential":[246],"treatment":[247,314],"other":[252],"mesothelin-expressing":[253,316],"tumors":[254],"involving":[255],"peritoneum,":[257],"provide":[259],"preclinical":[260],"proof":[261],"principle":[263],"tumors.":[268],"Citation":[269],"Format:":[270],"Chien-Fu":[271],"Hung,":[272],"Xuequn":[273],"Xu,":[274],"Linhong":[275],"Li,":[276],"Ying":[277],"Ma,":[278],"Qiu":[279],"Jin,":[280],"Angelia":[281],"Viley,":[282],"Cornell":[283],"Allen,":[284],"Pachai":[285],"Natarajan,":[286],"Rama":[287],"Shivakumar,":[288],"Madhusudan":[289],"V.":[290],"Peshwa,":[291],"Leisha":[292],"A.":[293],"Emens.":[294],"Development":[295],"anti-human":[297],"mesothelin":[298],"(CAR)":[302],"transfected":[306],"(CARMA)":[311],"cancers":[317],"[abstract].":[318],"In:":[319],"Proceedings":[320],"American":[323],"Association":[324],"Cancer":[326,339],"Research":[327],"Annual":[328],"Meeting":[329],"2017;":[330],"2017":[331],"Apr":[332],"1-5;":[333],"Washington,":[334],"DC.":[335],"Philadelphia":[336],"(PA):":[337],"AACR;":[338],"Res":[340],"2017;77(13":[341],"Suppl):Abstract":[342],"nr":[343],"3748.":[344],"doi:10.1158/1538-7445.AM2017-3748":[345]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-08-08T00:00:00"}